Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.
Ahluwalia MS, Ozair A, Drappatz J, Ye X, Peng S, Lee M, Rath S, Dhruv H, Hao Y, Berens ME, Walbert T, Holdhoff M, Lesser GJ, Cloughesy TF, Sloan AE, Takebe N, Couce M, Peereboom DM, Nabors B, Wen PY, Grossman SA, Rogers LR.
Ahluwalia MS, et al. Among authors: ye x.
Clin Cancer Res. 2024 Aug 1;30(15):3167-3178. doi: 10.1158/1078-0432.CCR-23-4098.
Clin Cancer Res. 2024.
PMID: 38836759
Clinical Trial.